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Enterovirus 71 (EV71) can cause brain encephalitis and mortality. However, effective vaccines or
chemotherapeutic agents are not yet available. We tested the hypothesis that Pueraria lobata could
inhibit the cytotoxic effect of EV71 in a human foreskin fibroblast cell line by the XTT method.
Our results showed that the water extract of P. lobata could inhibit cytopathy induced by EV71
when given before (p < 0.0001), simultaneously with (p < 0.0001), or after viral infection
(p < 0.0001). Water extract of P. lobata was effective and its minimal concentration that inhibited
50% of the cytopathic effect (IC50) was 0.028 μg/mL. P. lobata was also safe with a selectivity index
greater than 107,000. Water extract of P. lobata appeared to inhibit viral attachment (p < 0.0001)
and penetration (p < 0.0001). The anti-EV71 activity of the water extract of P. lobata was not medi-
ated by interferons. In conclusion, the water extract of P. lobata was effective in the management
of the disease induced by EV71 infection.
Key Words: chemoprevention, enterovirus, EV71, Pueraria lobata, therapy
(Kaohsiung J Med Sci 2008;24:523–30)
Kaohsiung J Med Sci October 2008 • Vol 24 • No 10
Enterovirus infection is a common disease encoun-
tered worldwide. It can infect without major symp-
toms [1]. However, it can also cause severe forms of
disease, such as infection of the central nervous sys-
tem (CNS), with mortality and neurologic sequelae
[2]. Enterovirus 71 (EV71) is a common enterovirus
that usually causes hand, foot and mouth disease
(HFMD) [3]. Nevertheless, EV71 can cause brainstem
encephalitis and death [3,4]. EV71 caused an out-
break with 78 mortalities in Taiwan in the early 1990s
[4]. Most of the victims were younger than 5 years of
age. They died of CNS involvement and cardiopul-
monary failure [4]. Furthermore, survivors of EV71
CNS infection often have neurologic sequelae and
delayed neurodevelopment [5]. Therefore, effective
management is crucial. Unfortunately, effective agents
and vaccines are not currently available [6]. Further-
more, EV71 is easily transmitted, mainly by the fecal–
oral route [7] in a crowded environment with poor
public hygiene. Therefore, a large outbreak will place
a heavy burden on the Bureau of National Health 
Insurance. A cheap, readily available, effective thera-
peutic modality is urgently required.
Ge Gen Tang (GGT) has been used to manage
upper respiratory airway diseases for thousands of
years in ancient China. Most upper respiratory air-
way diseases are caused by viruses; therefore, GGT
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appears to have antiviral activity. Pueraria lobata, one
of the earliest medicinal plants used in traditional
Chinese medicine, is the main ingredient of GGT. It has
been used for thousands of years with several clinical
applications, such as coronary dilatation, and possesses
antispasmodic, antipyretic, prokinetic, antihyperten-
sive and antihyperglycemic properties [8]. Recently,
P. lobata has become famous for its use as a hangover/
alcoholism remedy to treat alcohol-related problems
[9–11]. P. lobata is still commonly used to manage flu-
like syndromes. Therefore, P. lobata is believed to
have antiviral activity. However, such antiviral activ-
ity has not been studied. The initial presentations of
EV71 infection might mimic flu symptoms; therefore,
we tested the hypothesis that P. lobata is effective on
cytopathy induced by EV71.
METHODS
Preparation of plant extracts
Pueraria lobata Ohwi (Pueraria lobata) was collected
from markets in South Taiwan. The authenticity was
confirmed by Professor M.H. Yen of the Graduate In-
stitute of Natural Products of Kaohsiung Medical
University. A water extract of P. lobata was prepared as
previously reported [12]. Briefly, 100 g of P. lobata were
shade-dried and decocted for 1 hour with 1L of boiling
reverse-osmosis-treated water three times. The decoc-
tions were mixed, filtered, concentrated and lyoph-
ilized. The w/w (weight/weight) yield of P. lobata was
18.2%. The extract of P. lobata was dissolved in mini-
mum essential medium (MEM) supplemented with
10% fetal calf serum (FCS) into the final concentra-
tions of 0.01, 0.03, 0.1, 0.3, 1, 3, 10 and 30 μg/mL for
bioactivity and up to 3,000 μg/mL for cytotoxicity
tests before the experiments.
Reagents, cell and viruses
XTT (sodium 3-[1-(phenylamino-carbonyl)-3,4-
tetrazolium]-bis (4-methoxy-6-nitro) benzene sulfonic
acid) kits were purchased from Roche Diagnostics
GmbH (Mannheim, Germany). Ribavirin (Sigma, St.
Louis, MO, USA), a well-known wide-spectrum antivi-
ral agent [13], was used as a positive control and 0.1%
DMSO as a negative control. Reagents and medium
for cell culture were purchased from Gibco BRL
(Grand Island, NY, USA). A human foreskin fibro-
blast cell line (CCFS-1/KMC) [14] was used to culture
clinically isolated EV71 (BrCr strain, GenBank acces-
sion no. U22521). Cells were propagated at 37°C under
5% CO2 in MEM supplemented with 10% FCS, 100 U/
mL penicillin G sodium, 100 μg/mL streptomycin
sulfate and 0.25μg/mL amphotericin B. The virus was
propagated on a 90% confluent cell monolayer in MEM
with 2% FCS and antibiotics as described above. Viral
titer was determined by the cytopathic effect (CPE)
and expressed as 50% tissue culture infective dose
(TCID50) per milliliter (mL). The virus was stored at 
−70°C until use.
Cytotoxicity assay
The cytotoxic effect of water extract of P. lobata on pro-
liferating cells was assayed using an XTT-based meth-
od [15,16]. Briefly, cells (1×104 cells/well) were seeded
into 96-well culture plates (Falcon; BD Biosciences,
NJ, USA) and were incubated overnight at 37°C
under 5% CO2. Then, the medium was removed and
different concentrations (100, 300, 1,000 or 3,000 μg/
mL) of the extract of P. lobata were applied to tripli-
cate wells. After incubation for 3 days, the cytotoxic-
ity of the concentrations was determined using the
XTT assay according to the manufacturer’s instruc-
tions. The 50% cytotoxic concentration (CC50) of the
extract was calculated by regression analysis of the
dose-response curve.
Antiviral effectiveness assay and
selectivity index
The anti-EV71 activity of water extract of P. lobata was
assayed by the XTT method, as described previously
[15,16]. Briefly, cells (1 × 104 cells/well) were plated
into 96-well culture plates for incubation of 72 hours.
The medium was removed and cells were infected
with 100 TCID50 of EV71. Then, various concentrations
of the extract were added immediately and samples
were incubated for another 72 hours. Each experi-
ment was tested in triplicate and performed at least
three times separately. Then, the medium was aspi-
rated and the cytoprotective activity was determined
using the XTT assay according to the manufacturer’s
instructions. The absorbance at 492 nm (A492 nm) was
determined with an enzyme-linked immunosorbent
assay (ELISA) reader (Multiskan EX, Labsystems,
Helsinki, Finland) with a reference of A690 nm. The
cytoprotection rate (percent of control) was calculated
as follows: (A492tv − A492cv)/(A492cd − A492cv) × 100%,
where A492tv is the absorbance of the test compound
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with virus-infected cells, A492cv is the absorbance of
viral control, and A492cd is the absorbance of the cell
control only. The antiviral activity of the P. lobata extract
with its minimal concentration required to inhibit 
the 50% CPE of EV71 (IC50) was estimated [15,16].
The selectivity index (SI) was calculated as the ratio
of CC50 to IC50.
Time course assay
The antiviral activity of the water extract of P. lobata
was also examined at different times before and after
viral infection [15,16]. Briefly, cells (1 × 104 cells/well)
were seeded and incubated for 24 hours, as previously
described. The cell monolayer was then infected with
100 TCID50 of EV71. Different concentrations of the
extract were added to the wells at −2 and −1 hour 
(2 and 1 hour before viral inoculation, respectively)
and at 1 and 2 hours (1 and 2 hours after viral inocu-
lation, respectively). They were incubated for a fur-
ther 72 hours and assayed with the XTT reagent as
described above.
Attachment assay
The water extract of P. lobata was evaluated for its
effect on viral attachment [16]. Briefly, cells (1 × 104
cells/well) were seeded and incubated for 48 hours,
as previously described. Cells were pre-chilled at 4°C
for 1 hour and the medium was aspirated. The cell
monolayer was then infected with 200 TCID50 of
EV71 with different concentrations of the extract.
After incubation at 4°C for another 3 hours, the med-
ium was aspirated to remove unadsorbed virus. The
cell monolayer was then washed with phosphate-
buffered saline (PBS) three times and incubated for a
further 72 hours and assayed with the XTT reagent as
described above.
Penetration assay
The effect of the water extract of P. lobata on viral 
penetration was also evaluated [16]. Briefly, the cell
monolayer was grown in 96-well culture plates and
pre-chilled at 4°C for 1 hour. The cell monolayer was
then infected with EV71 of 200 TCID50 and incubated
at 4°C for another 3 hours to allow viral attachment
to the cell surface. Then, various concentrations of
the extract were supplemented. They were incubated
at 37°C under 5% CO2 for a further 1 hour to maxi-
mize the penetration of viruses. At 10-minute intervals,
the infected cell monolayer was treated with alkaline
PBS (pH 11) for 1 minute to inactivate unpenetrated
virus. Then, acidic PBS (pH 3) was added immedi-
ately to neutralize the alkaline PBS (pH 11). The neu-
tral PBS was removed immediately and the cell
monolayer was supplemented with fresh viral cul-
ture medium (MEM plus 2% FCS). After incubation
at 37°C for a further 72 hours, the cell monolayer was
assayed with the XTT reagent as described above.
Interferon assay
After treatment of the cells described in the above
section titled “Antiviral effectiveness assay and selec-
tivity index”, the culture medium was collected 
and assayed by the interferon (IFN)-beta ELISA kit
(PBL Biomedical Laboratories, Piscataway, NJ, USA)
according to the manufacturer’s instructions. Briefly,
100 μL of culture medium was placed into a 96-well
microplate precoated with IFN-β antibodies. This was
incubated at room temperature for 1 hour. After clear-
ance by washing buffer, the wells were incubated
with 100 μL/well peroxidase-conjugated IFN-β anti-
bodies for another 1 hour. Then, they were washed
again and were reincubated with 100 μL/well TMB
substrate at room temperature in the dark for another
15 minutes. Finally, 100 μL/well 2N H2SO4 was sup-
plemented to terminate the reaction. The A450 nm 
was determined with ELISA reader (Multiskan EX,
Labsystems).
Statistical analysis
Results are expressed as mean ± standard deviation
(SD). The IC50 and CC50 values were calculated by
Microsoft Excel 2003. The percentage of controls (cyto-
protection; %) was used for statistical analysis with
ANOVA by JMP version 6.0 software (SAS Institute,
Cary, NC, USA). Tukey’s honestly significant difference
(HSD) test was used to compare all pairs of groups 
in the ANOVA test. A p value < 0.05 was considered
statistically significant.
RESULTS
Cytotoxicity assay
The water extract of P. lobata did not show cytotoxic-
ity against host cells at concentrations up to 3,000 μg/
mL (Figure 1). The estimated CC50 was more than
3,000 μg/mL. The high CC50 indicates its safety for
daily use.
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Antiviral effectiveness assay and SI
The water extract of P. lobata was effective (p < 0.0001;
Figure 2) against the BrCr strain of EV71 at a concen-
tration of 0.03 μg/mL. The estimated minimal con-
centration required to inhibit the 50% CPE of EV71
(IC50) with the extract of P. lobata was 0.028 μg/mL.
This IC50 was far smaller than its cytotoxic concentra-
tion (> 3,000 μg/mL), giving a very high SI exceeding
107,000. Therefore, the extract of P. lobata was an
effective and safe agent.
Time course assay
After validating the anti-EV71 effectiveness of the
water extract of P. lobata with simultaneous supple-
mentation, it was of interest to know whether the 
extract of P. lobata could work before and/or after
EV71 infection. Our results showed that the extract of
P. lobata could significantly inhibit the CPE of EV71
when supplemented either before or after viral infec-
tion (p < 0.0001; Figure 3). The minimal effective con-
centration was 0.1 μg/mL when added either before
or after viral infection. This potent effectiveness of the
water extract of P. lobata against EV71 could be bene-
ficial for prevention and/or treatment. There was no
statistical difference in effectiveness between the dif-
ferent concentrations tested.
Attachment assay
Because the water extract of P. lobata had anti-EV71
activity before viral infection, we hypothesized that
the extract of P. lobata might inhibit viral attachment
and/or penetration to prevent viral entrance into cells.
After performing the attachment assay, we found that
the extract of P. lobata could significantly inhibit viral
attachment to enter the host cell at concentrations
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Figure 1. Cytotoxicity assay of water extract of P. lobata. The
extract of P. lobata did not show any cytotoxicity against host
cells at concentrations up to 3,000mg/mL. The estimated CC50
exceeded 3,000mg/mL. Data are mean ± standard deviation of
three independent experiments.
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Figure 2. Antiviral effectiveness of water extract of P. lobata
against the BrCr strain of EV71. The extract of P. lobata inhibited
the cytopathic effects induced by the EV71 BrCr strain at a 
concentration of 0.03mg/mL (p < 0.0001). The estimated IC50 of
the extract of P. lobata was 0.028mg/mL, with an antiviral selec-
tivity index > 107,000. Data are mean ± standard deviation of
nine determinations. *p < 0.05 vs. control.
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Figure 3. Time course assay of the water extract of P. lobata against
EV71 infection. The extract of P. lobata significantly inhibited
the cytopathic effect of EV71 when administered before (−2 and 
−1 hours) or after (+1 and +2 hours) viral infection (p < 0.0001).
The effectiveness was lower when given 1 hour before viral infec-
tion (−1 hour). Data are presented as mean ± standard deviation
of nine determinations. *p < 0.05 vs. control.
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greater than 0.3μg/mL (p<0.0001; Figure 4). The effec-
tiveness showed a trend towards decreased effective-
ness. However, there was no statistical significance.
Penetration assay
We also found that the water extract of P. lobata could
effectively inhibit viral penetration at concentrations
greater than 0.1 μg/mL (p < 0.0001; Figure 5). The
extract of P. lobata exerted its effect during the early
stage of penetration. There was a trend that increasing
the incubation time with extract of P. lobata increased
its effectiveness. However, there was no statistical dif-
ference between the various treatment durations. This
activity to inhibit viral penetration could be additive
to the antiviral attachment effect to prevent viral
entrance.
IFN assay
EV71 infection (0μg/mL P. lobata+EV71; Figure 6) sig-
nificantly increased IFN production above the consti-
tutive level (0 μg/mL P. lobata; p = 0.037). The water
extract of P. lobata effectively decreased the IFN pro-
duction induced by EV71 infection (p < 0.05). There-
fore, its anti-EV71 activity was not mediated by IFN.
DISCUSSION
Our experiment has demonstrated that the water ex-
tract of P. lobata was highly effective against cytopathy
induced by EV71 infection. The extract of P. lobata had
anti-EV71 activity whether supplemented before or
after viral infection. We have provided evidence of its
effect on viral attachment and penetration. However, its
effect on viral replication needs to be clarified in fu-
ture studies after its lifecycle becomes better under-
stood. The extract of P. lobata exerted its anti-EV71
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Figure 4. Attachment assay of the water extract of P. lobata
against EV71 infection. The extract of P. lobata significantly
inhibited viral attachment and entry into the host cell at con-
centrations > 0.3mg/mL (p < 0.0001). Data are mean ± standard
deviation of nine determinations. *p < 0.05 vs. control.
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Figure 5. Penetration assay of the water extract of P. lobata
against EV71 infection. The extract of P. lobata significantly
inhibited the penetration of EV71 at concentrations > 0.1mg/mL
(p < 0.0001). The effect developed rapidly within 10 minutes.
Data are mean ± standard deviation of nine determinations.
*p < 0.05 vs. control.
p = 0.038
0
0 1 3 10 30
5
10
15
20
25
30
35
P. lobata concentration (μg/mL)
IF
N
 c
on
ce
nt
ra
ti
on
 (p
g/
m
L
)
P. lobata
P. lobata + EV71
*
* *
*
Figure 6. Effect of the water extract of P. lobata on interferon
(IFN) production induced by EV71 infection. EV71 infection
(0mg/mL P. lobata) significantly enhanced IFN production above
the constitutive level (cells only). The extract of P. lobata decreased
IFN production induced by EV71 infection (p < 0.05). Data are
mean ± standard deviation of three independent experiments.
*p < 0.05 vs. control.
activity at a concentration of 0.03 μg/mL. The low
IC50 (0.028μg/mL) with high SI (>107,000) means that
the P. lobata extract is a good candidate for the treat-
ment of disease induced by EV71 infection. Large
quantities of effective agents are needed during an
outbreak, and this would involve huge medical expen-
diture and heavy financial burden on the government.
However, because the water extract of P. lobata is a
simple to prepare, crude extract of a medicinal plant,
it is relatively cheap. Therefore, it is estimated that the
cost to protect a child from EV71 infection would be
less than NT$1 per day. Considering its effectiveness
without clear cytotoxicity, the water extract of P. lobata
could be taken regularly during the endemic period.
This high effectiveness of a cheap crude extract of a
medicinal plant has offered an approach to prevent
EV71 infection during an outbreak. However, EV71 is
a genetically diverse, rapidly evolving virus [17]. Viral
mutation with drug resistance could develop rapidly
after introducing chemotherapeutic agents into dis-
ease control. It is still unknown whether the extract of
P. lobata is effective against mutant strains. Further-
more, its safety in neonates is also unknown.
Fundamentally, viral infection could induce cellu-
lar IFN production to limit viral spread. Increases in
IFN levels above the basal level are also found dur-
ing EV71 infection. However, abnormal cytokine pro-
duction during EV71 infection could be associated with
fatality. Severely ill patients with pulmonary edema
have significantly higher serum IFN levels [18,19]. Ear-
ly administration of intravenous immunoglobulin can
decrease IFN levels and were associated with lower
mortality rates in patients with EV71 infection and
pulmonary edema [20]. We found that the extract of
P. lobata could counteract IFN production induced by
EV71 infection (Figure 6). Therefore, the extract of 
P. lobata might have additional benefits to manage dis-
ease caused by EV71 infection. However, the impact
of IFN on disease progress is still debated. Therefore,
the beneficial effects of the water extract of P. lobata on
IFN production need further testing and verification.
We have demonstrated that the water extract of
P. lobata is highly effective against EV71 infection in 
a foreskin fibroblast cell line. However, neurotropic
EV71 can be fatal after CNS involvement. Our exper-
imental model does not support P. lobata as being
effective for the management of EV71 encephalitis.
Nevertheless, lipophilic substances, rather than aque-
ous extracts, can better access brain tissue; thus, 
scientists might doubt the usefulness of the water
extract of P. lobata. However, the peak incidence of
EV71 encephalitis occurs at around the same time as
the peak of HFMD [4]. Therefore, as the number of
patients infected with EV71 increases, the number 
of patients affected by EV71 encephalitis will also
increase. A reduction in the EV71-infected population
might decrease the incidence of EV71 encephalitis.
Therefore, it is rational to use the water extract of 
P. lobata during an endemic period of HFMD to prevent
further fatal brain stem encephalitis.
In conclusion, the water extract of P. lobata was
effective for the inhibition of cytopathy induced by
EV71. The water extract of P. lobata is cheap and read-
ily available and could be beneficial to prevent and
limit the spread of EV71 during endemic outbreaks.
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葛根 (Pueraria lobata) 熱水萃取物在人類包皮
纖維母細胞株抑制腸病毒 71 型造成的細胞毒性
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腸病毒 71 型 (EV71) 可導致腦性腦炎和死亡。但是目前並無有效的疫苗，也沒有化療
藥物可用於治療腸病毒 71 型造成的感染。我們利用人類包皮纖維母細胞株以及 XTT 
方法檢定葛根熱水萃取物能有效抑制腸病毒 71 型的細胞毒性作用。我們的結果顯
示，葛根熱水萃取物能有效抑制腸病毒 71 型感染產生的細胞毒性作用。在病毒感染
前投與 (p < 0.0001)，在病毒感染時投與 (p < 0.0001)，或在病毒感染之後投與 (p < 
0.0001)，皆能顯示葛根熱水萃取物有效抑制腸病毒 71 型感染造成的細胞毒殺作用。
本實驗證實葛根熱水萃取物抑制腸病毒 71 型是有效 (IC50 為 0.028 μg/mL) 而且安
全 (選擇指數大於 107000)。葛根可能可以抑制病毒附著 (p < 0.0001) 和穿透 (p < 
0.0001) 細胞的過程。葛根熱水萃取物不會增加腸病毒 71 型感染產生的干擾素，因此
其作用機轉和干擾素無關。結論為葛根熱水萃取物將來可能可用於腸病毒 71 型感染
的防治。
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